Article metrics

Download PDFPDF

721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection

 

Online download statistics by month:

Online download statistics by month: November 2020 to January 2024

AbstractFullPdf
Nov 2020106013
Dec 20202207
Jan 20212004
Feb 20211805
Mar 20212606
Apr 202136012
May 2021409
Jun 20210012
Jul 2021001
Aug 2021006
Sep 2021006
Oct 202110018
Nov 202116013
Dec 20212807
Jan 20221004
Feb 20223009
Mar 20221205
Apr 20225808
May 20222203
Jun 20222006
Jul 20223004
Aug 20225004
Sep 20223007
Oct 20222006
Nov 20222403
Dec 20223806
Jan 20233203
Feb 20232604
Mar 20231805
Apr 20232205
May 20233203
Jun 202320015
Jul 202312016
Aug 20231403
Sep 20232005
Oct 20232409
Nov 20231804
Dec 20233603
Jan 20241000
Total9140259